rTMS as an Intervention for Levodopa-induced Dyskinesia
RecruitingNCT06570824Phase: NAStarted 2024-07-22
Summary
The proposed study investigates the use of repetitive transcranial magnetic stimulation (rTMS) as a treatment for levodopa-induced dyskinesia (LID) in Parkinson's Disease (PD). Specifically, the study
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Locations
DRCMRHvidovre, Denmark
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06570824